Guangzhou LBP Medicine Science & Technology Co., Ltd.SSE: 688393

Announcement on Expected Loss in Performance for 2025

Jan 31, 2026 · Issued by Guangzhou LBP Medicine Science & Technology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 31, 2026

On 6ix: 6ix.com/news/announcement-on-expected-loss-in-performance-for-2025-152

Announcement on Expected Loss in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Guangzhou LBP Medicine Science & Technology Co., Ltd. on 6ix

Earlier from Guangzhou LBP Medicine Science & Technology

Announcement on Shareholding Reduction Plan for ShareholdersJan 19
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jan 15
Announcement on Result of Shareholding Reduction by ShareholderJan 10
Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from October to December 2025Jan 9
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares in Total Reaching 1% ScaleDec 31, 2025

Later from Guangzhou LBP Medicine Science & Technology

Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on the Estimated Amount of Daily Related Party Transactions in 2026Mar 27
Announcement on Voluntary Disclosure of Cervical Cell Digital Pathology Image Assisted Diagnosis Software Receiving Class III Medical Device Registration CertificateMar 31
Announcement on Change of Accounting PoliciesApr 2
Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from January to March 2026Apr 9

All Guangzhou LBP Medicine Science & Technology news releases

Follow Guangzhou LBP Medicine Science & Technology into a list and get an email when it puts out news.

Follow Guangzhou LBP Medicine Science & Technology